Clinical Trials Directory

Trials / Unknown

UnknownNCT06045715

Follow-up Strategy for Esophageal Cancer Patients

An Optimized Post-surgery Follow-up Strategy for Patients With Esophageal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The recurrence risk of patients with esophageal cancer was stratified by integrating different stages and pathological factors. The risk of recurrence was dynamically estimated for each group of patients, and the optimal follow-up strategy was developed based on the recurrence risk.

Detailed description

Patients with histologically proven, esophageal cancer (EC) patients diagnosed between 2008 and 2018 were recruited. Recursive partition analysis was applied to develop recurrence risk stratification for patients. The follow-up strategies of each stratification were developed based on monthly recurrence probability and validated by bootstrap validation and an external dataset. Markov decision-analytic models were constructed to evaluate the cost-effectiveness of the follow-up strategies.

Conditions

Interventions

TypeNameDescription
OTHERfollow-up with different time intervalsAfter radical surgery, patients are followed up with different time intervals

Timeline

Start date
2022-08-20
Primary completion
2023-06-30
Completion
2023-12-01
First posted
2023-09-21
Last updated
2023-09-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06045715. Inclusion in this directory is not an endorsement.